Avails Medical to start antibiotic susceptibility testing trial

2021 10 06 22 07 0734 Antibiotics Concept 400

Avails Medical has begun a clinical trial for its eQuant electrical antibiotic susceptibility testing system, the results of which it expects to use in a submission for eQuant clearance from the U.S. Food and Drug Administration (FDA).

eQuant produces an inoculum from a blood culture in about 40 minutes, which helps clinicians better assess the effects of antibiotic treatment, according to Avails Medical. It can be used with traditional automated antimicrobial susceptibility testing systems and with disk diffusion, speeding turnaround times by as much as one day, the company said.

Page 1 of 162
Next Page